TY - JOUR
T1 - Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling
AU - Robson, Neil C.
AU - Hidalgo, Laura
AU - McAlpine, Tristan
AU - Wei, Heng
AU - Martínez, Víctor G.
AU - Entrena, Ana
AU - Melen, Gustavo J.
AU - MacDonald, Andrew S.
AU - Phythian-Adams, Alexander
AU - Sacedón, Rosa
AU - Maraskovsky, Eugene
AU - Cebon, Jonathan
AU - Ramírez, Manuel
AU - Vicente, Angeles
AU - Varas, Alberto
PY - 2014/7/18
Y1 - 2014/7/18
N2 - © 2014 American Association for Cancer Research.Natural killer (NK) cells are critical for innate tumor immunity due to their specialized ability to recognize and kill neoplastically transformed cells. However, NK cells require a specific set of cytokine-mediated signals to achieve optimal effector function. Th1-associated cytokines promote effector functions that are inhibited by the prototypic Th2 cytokine IL4 and the TGFβ superfamily members TGFβ1 and activin-A. Interestingly, the largest subgroup of the TGFβ superfamily are the bone morphogenetic proteins (BMP), but the effects of BMP signaling on NK cell effector functions have not been evaluated. Here, we demonstrate that blood-circulating NK cells express type I and II BMP receptors, BMP-2 and BMP-6 ligands, and phosphorylated isoforms of Smad-1/-5/-8, which mediate BMP family member signaling. In opposition to the inhibitory effects of TGFβ1 or activin-A, autocrine BMP signaling was supportive to NK cell function. Mechanistic investigations in cytokine and TLR-L-activated NK cells revealed that BMP signaling optimized IFNγ and global cytokine and chemokine production, phenotypic activation and proliferation, and autologous dendritic cell activation and target cytotoxicity. Collectively, our findings identify a novel auto-activatory pathway that is essential for optimal NK cell effector function, one that might be therapeutically manipulated to help eradicate tumors.
AB - © 2014 American Association for Cancer Research.Natural killer (NK) cells are critical for innate tumor immunity due to their specialized ability to recognize and kill neoplastically transformed cells. However, NK cells require a specific set of cytokine-mediated signals to achieve optimal effector function. Th1-associated cytokines promote effector functions that are inhibited by the prototypic Th2 cytokine IL4 and the TGFβ superfamily members TGFβ1 and activin-A. Interestingly, the largest subgroup of the TGFβ superfamily are the bone morphogenetic proteins (BMP), but the effects of BMP signaling on NK cell effector functions have not been evaluated. Here, we demonstrate that blood-circulating NK cells express type I and II BMP receptors, BMP-2 and BMP-6 ligands, and phosphorylated isoforms of Smad-1/-5/-8, which mediate BMP family member signaling. In opposition to the inhibitory effects of TGFβ1 or activin-A, autocrine BMP signaling was supportive to NK cell function. Mechanistic investigations in cytokine and TLR-L-activated NK cells revealed that BMP signaling optimized IFNγ and global cytokine and chemokine production, phenotypic activation and proliferation, and autologous dendritic cell activation and target cytotoxicity. Collectively, our findings identify a novel auto-activatory pathway that is essential for optimal NK cell effector function, one that might be therapeutically manipulated to help eradicate tumors.
U2 - 10.1158/0008-5472.CAN-13-2845
DO - 10.1158/0008-5472.CAN-13-2845
M3 - Article
C2 - 25038228
SN - 1538-7445
VL - 74
SP - 5019
EP - 5031
JO - Cancer Research
JF - Cancer Research
IS - 18
ER -